VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
113 hedge funds and large institutions have $1.08B invested in Verona Pharma in 2024 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 44 increasing their positions, 28 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
113
Holders Change
-4
Holders Change %
-3.42%
% of All Funds
1.64%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.1%
New
15
Increased
44
Reduced
28
Closed
19
Calls
$1.26M
Puts
$1.55M
Net Calls
-$297K
Net Calls Change
+$2.36M
Top Buyers
| 1 |
CP
Caligan Partners
New York
|
+$17.9M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$13M |
| 3 |
ABG
Ally Bridge Group
New York
|
+$11.9M |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$9.19M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$5.45M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$51M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$15.5M |
| 3 |
VC
Vivo Capital
Palo Alto,
California
|
-$10.3M |
| 4 |
Morgan Stanley
New York
|
-$10.1M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$7.67M |
